Ki20227
623142-96-1
95%
2026-06-29
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Product Description
-
Seller Information
-
Description
ProductName Ki20227 Cat No CEI-1096 Description Ki20227, a c-fms tyrosine kinase inhibitor, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model. Abbr Ki20227(CSF1R) Alias C-FMS, CD115, CSF-1R, CSFR, FIM2, FMS, HDLS, M-CSF-R Product Overview c-fms tyrosine kinase inhibitor CAS No 623142-96-1 Molecular Weight 480.54 Purity > 95% Stability 2 years -20 centigrade Powder1 month -4 centigrade in DMSOMore than one month -80 centigrade in DMSO Storage 4 centigrade Synonyms C-FMS, CD115, CSF-1R, CSFR, FIM2, FMS, HDLS, M-CSF-R Targets c-Fms Molecular Formula C24H24N4O5S Chemical Name (N-{4-[(6,7-dimethoxy-4-quinolyl)oxy]-2-methoxyphenyl}-N'-[1-(1,3-thiazole-2-yl)ethyl]urea) Solubility DMSO > 112mg/mL Water >1mg/mL Ethanol > 4mg/mL category Specialty Chemicals(c26) cas_num 623142-96-1 Basic Info-
Product Name:
N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]-2-methoxyphenyl]-N'-[1-(2-thiazolyl)ethyl]urea
Other Name:N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]-2-methoxyphenyl]-N'-[1-(2-thiazolyl)ethyl]urea;Ki20227;Urea, N-[4-[(6,7-diMethoxy-4-quinolinyl)oxy]-2-Methoxyphenyl]-N'-[1-(2-thiazolyl)ethyl]-;1-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)-2-methoxyphenyl)-3-(1-(thiazol-2-yl)ethyl)urea;KI20227; KI 20227;CS-1094;KI20227; KI-20227; KI 20227;1-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2-methoxyphenyl]-3-[1-(1,3-thiazol-2-yl)ethyl]urea
CAS No.:623142-96-1
Molecular Formula:C24H24N4O5S
InChIKeys:SHPFDGWALWEPGS-UHFFFAOYSA-N
Molecular Weight:480.54
Exact Mass:480.14674105
EC Number:200-258-5
DSSTox ID:DTXSID80432108
Categories:
Characteristics-
Density:
1.327
Boiling Point:621.8±55.0 °C(Predicted)
PKA:12.03±0.46
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Location:
Shirley, New York 11967, USA
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
15
-
Total Annual Revenue:
$1 million-$2.5 million
-
Year of Establishment:
2004
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product